drugset / Trial / NCT00437450
Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is * To evaluate the efficacy of association of Erythropoetin (Neorecormon) and ATRA in patients with low risk myelodysplastic syndromes * To evaluate the tolerance of this treatment
Timeline
- Start
- 2004-10
- Primary completion
- —
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tretinoin | Unknown | — | — |
| Subject | epoetin alfa | Protein / enzyme biologic | — | — |